Avery Dennison Q3 2026 10-Q: Quarterly Results for Period Ended September 30, 2026

Avery Dennison Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 3, 2026, covering the company's fiscal third quarter financial results.

Key Highlights

  • Quarterly period covered: The report covers the three and nine months ended September 30, 2026, compared with the period ended September 27, 2025.
  • Cash and cash equivalents: The company reported cash and cash equivalents of $271.4 million as of September 30, 2026, up from $202.8 million as of December 31, 2025.
  • Shares outstanding: As of October 31, 2026, there were 75,511,437 shares of $1 par value common stock outstanding.
  • Trade accounts receivable allowances: Allowances for trade accounts receivable stood at $28.1 million as of September 30, 2026.
  • Filer classification: Avery Dennison is classified as a large accelerated filer and confirmed it is not a shell company.
  • Listed securities: Common stock trades on NYSE:AVY; the 3.750% Senior Notes due 2034 (AVY34) and 4.000% Senior Notes due 2035 (AVY35) trade on NASDAQ.

Avery Dennison's Fiscal Third Quarter 2026 Financial Position and Filing Details

Avery Dennison Corporation (NYSE:AVY), headquartered at 8080 Norton Parkway, Mentor, Ohio 44060, filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The filing covers both the three-month and nine-month periods, with comparative figures drawn from the period ended September 27, 2025. The company's condensed consolidated financial statements are presented on an unaudited basis, as disclosed in the filing.

According to the filing, cash and cash equivalents increased to $271.4 million as of September 30, 2026, compared with $202.8 million as of December 31, 2025. Trade accounts receivable are reported net of allowances of $28.1 million as of September 30, 2026. The filing indicates that 75,511,437 shares of $1 par value common stock were outstanding as of October 31, 2026. In addition to its common stock listed on the New York Stock Exchange under the symbol AVY, the company has two series of senior notes listed on the Nasdaq Stock Market: the 3.750% Senior Notes due 2034 (AVY34) and the 4.000% Senior Notes due 2035 (AVY35).

The filing contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which the company notes are subject to risks and uncertainties. Among the risk factors the company identified as potentially significant in the near term are: the impact of global economic conditions, tariffs, and geopolitical uncertainty on product demand; competitive actions; raw material costs and availability; foreign currency fluctuations; and acquisition execution and integration. The company stated that its forward-looking statements "are made only as of the filing date of this Form 10-Q" and that it assumes "no duty to update these forward-looking statements," except as required by law.

What Was Disclosed

Avery Dennison filed its fiscal third quarter 2026 Form 10-Q, reporting cash of $271.4 million, 75,511,437 shares outstanding as of October 31, 2026, and trade receivable allowances of $28.1 million as of September 30, 2026, alongside its condensed consolidated financial statements and management discussion.